UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. ___)*
MOORE MEDICAL CORP.
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
(Title of Class of Securities)
615795103
(CUSIP Number)
HOLLYBANK INVESTMENTS, LP
P.O. BOX 190240
MIAMI BEACH, FLORIDA 33119
(617) 310-5110
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
AUGUST 31, 1999(1)
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
( ).
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
- ------------------
1 Hollybank Investments LP, Thistle Investments LLC and Dorsey R. Gardner have
previously filed a timely Schedule 13G. This Schedule 13D is being filed to
bring Hollybank Investments, Thistle Investments LLC and Dorsey R. Gardner under
the current filing regime.
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 2 of 10 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Hollybank Investments, LP
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) ( )
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 331,600
OWNED BY
-----------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON WITH None
-----------------------------------------------------------
9 SOLE DISPOSITIVE POWER
331,600
-----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
331,600
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
( )
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.3%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 3 of 10 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Thistle Investments LLC
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) ( )
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 21,900
OWNED
BY
----------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON WITH None
----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
21,900
----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
21,900
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
( )
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 4 of 10 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dorsey R. Gardner
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) ( )
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 13,514XX
SHARES XX Please refer to Item 5, page 5 for disclaimer of
BENEFICIALLY beneficial ownership
---------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING None
PERSON WITH
---------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
13,514XX
XXPlease refer to Item 5, page 5 for disclaimer of
beneficial ownership
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,514XX
XX Please refer to Item 5, page 5 for disclaimer of beneficial
ownership
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* (X)
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.5%XX
XXPlease refer to Item 5, page 5 for disclaimer of beneficial ownership
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 5 of 10 Pages
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 6 of 10 Pages
ITEM 1. SECURITY AND ISSUER.
The title of the class of equity securities to which this statement
relates is the Common Stock, par value $0.01 per share (the "Shares"), of Moore
Medical Corp., a Delaware corporation (the "Company"). The address of the
Company's principal executive office is P.O. Box 1500, 389 John Downey Drive,
New Britain, Connecticut 06050.
ITEM 2. IDENTITY AND BACKGROUND
The persons filing this Statement are Hollybank Investments, LP, a
Delaware limited Partnership ("LP"), Thistle Investments LLC, a Delaware limited
liability company ("LLC") and Dorsey R. Gardner, the general partner of LP and
managing member of LLC ("Gardner"). The business address of Gardner, LP and LLC
is P.O. Box 190240, Miami Beach, Florida 33119. LP was formed on January 14,
1994, and is authorized to conduct any business which may be legally conducted
by a limited partnerhsip under the laws of Delaware. LLC was organized on
January 21, 1999 and is authorized to conduct any business which may be legally
conducted by a limited liability company under the laws of Delaware. As of the
date hereof, the sole business of each LP and LLC is securities investment.
During the last five years, neither Gardner, LP nor LLC has been convicted in a
criminal proceeding (excluding traffic violations and similar misdemenaors), nor
has Gardner, LP or LLC been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction as a result of which Gardner, LP
or LLC was or is subject to a judgement, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
This statement relates specifically to the following transactions in
the Shares: LP's August 18, 1999 purchase of 6,500 Shares at a per share price
of $9.10; and LP's August 19, 1999 purchase of 10,000 Shares at a per share
price of $9.55. These purchases, when aggregated with Gardner's and LP's
previously purchased Shares, gave Gardner deemed beneficial ownership of 367,014
of the 2,939,176 outstanding Shares, triggering this reporting requirement on
Schedule 13D. LP used its working capital for these purchases and every other
purchase. LLC used its working capital for its purchases, while Gardner used his
personal funds for his purchases.
ITEM 4. PURPOSE OF TRANSACTION.
LP, LLC and Gardner have acquired their respective shares strictly for
the purpose of equity security investment. Neither LP, LLC nor Gardner has any
present plans or proposals which would relate to or result in:
(a) The acquisition by any person of additional securities of the
Company, or the disposition of securities of the Company;
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 7 of 10 Pages
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Company or any of its subsidiaries;
(c) A sale or transfer of a material amount of assets of the Company or
any of its subsidiaries;
(d) Any change in the present board of directors or management of the
Company, including any plans or proposals to change the number of term of
directors or to fill any existing vacancies on the board;
(e) Any material change in the present capitalization or dividend
policy of the Company;
(f) Any other material change in the Company's business or corporate
structure;
(g) Changes in the Company's charter, bylaws or instruments
corresponding thereto or other actions which may impede the acquisition of
control of the Company by any person;
(h) Causing a class of securities of the Company to be delisted from a
national securities exchange or to cease to be authorized to be quoted in an
inter-dealer quotation system of a registered national securities association;
(i) A class of equity securities of the Company becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Securities
Exchange Act of 1934; or
(j) Any action similar to any of those enumerated above.
LP, LLC and Gardner have previously filed a Schedule 13G with the SEC.
A Schedule 13D is being filed because Gardner's total purchases exceed ten
percent of the Company's outstanding Shares.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a)(i) As of the date of this Statement, LP is the beneficial owner of
331,600 Shares (approximately 11.3% of the 2,939,176 outstanding Shares on July
29, 1999, based on information provided in the Company's most recent Quarterly
Report on Form 10Q filed August 13, 1999). Gardner, as general partner of LP,
may be deemed to beneficially own Shares beneficially owned by LP. Except to the
extent of his interest as a limited partner in LP, Gardner expressly disclaims
such beneficial ownership and the filing of this statement shall not be
construed as an admission that Gardner is the beneficial owner of the Shares
owned by LP and covered by this Statement.
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 8 of 10 Pages
(ii) As of the date of this Statement, LLC is the beneficial owner of
21,900 Shares (approximately 0.7% of the 2,939,176 outstanding Shares on July
29, 1999, based on information provided in the Company's most recent Quarterly
Report on Form 10Q filed August 13, 1999). Gardner, as managing member of LLC,
may be deemed to beneficially own Shares beneficially owned by LLC. Except to
the extent of his interest as a member in LLC, Gardner expressly disclaims such
beneficial ownership and the filing of this statement shall not be construed as
an admission that Gardner is the beneficial owner of the Shares owned by LLC and
covered by this Statement.
(iii) As of the date of this Statement, Gardner beneficially owns
13,514 Shares (approximately 0.5% of the 2,939,176 outstanding Shares as on July
29, 1999, based on information provided in the Company's most recent Quarterly
Report on Form 10Q filed August 13, 1999). Except to the extent of his interest
as a limited partner in LP and member of LLC, Gardner expressly disclaims
beneficial ownership of any Shares which may be beneficially owned by LP and
LLC, and the filing of this statement shall not be construed as an admission
that Gardner is the beneficial owner of such Shares.
(b) LP has sole voting power and sole investment power with respect to
the Shares reported in (a)(i) above. LLC has the sole voting power and sole
investment power with respect to the shares reported in (a)(ii) above. Gardner
has sole voting power and sole investment power with respect to the Shares
listed in (a)(iii) above.
(c)(i) Other than the acquisitions described in Item 3 above, LP has,
during the past 60 days, not effected any Share transactions.
(ii) LLC has, during the past 60 days, not effected any Share
transactions.
(iii) Gardner has, during the past 60 days, not effected any Share
transactions.
(d) No other person is known to have the right to receive or the power
to direct the receipt of dividends from, or the proceeds from the sale of Shares
reported on this Statement.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
There are no contracts, arrangement, understandings or relationships
(legal or otherwise) between LP, LLC or Gardner and any other person with
respect to any securities of the Company, including, but not limited to,
transfer or voting of any of the securities, finder's fees, joint ventures, loan
or option arrangements, puts or calls, guarantees of profits, division of
profits or loss, or the giving or withholding of proxies.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
The following document is filed herewith as an exhibit to this
statement:
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 8 of 10 Pages
(a) Joint Filing Agreement
(b) Power of Attorney
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
HOLLYBANK INVESTMENTS, LP
By:/s/ Timothy G. Caffrey
----------------------
Timothy G. Caffrey
General Partner
THISTLE INVESTMENTS LLC
By:/s/ Timothy G. Caffrey
----------------------
Timothy G. Caffrey
Managing Member
By:/s/ Timothy G. Caffrey
----------------------
Dorsey R. Gardner
By: Timothy G. Caffrey, Attorney-in-Fact
Date: September 3, 1999
<PAGE>
SCHEDULE 13D
CUSIP No. 615795103 Page 10 of 10 Pages
SCHEDULE 13D
EXHIBIT INDEX
99.1 Joint Filing Agreement. Filed herewith.
99.2 Power of Attorney. Filed herewith.
<PAGE>
EXHIBIT 99.1
AGREEMENT
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13D (or any amendment thereof) need be filed on their
behalf with respect to the beneficial ownership of any equity securities of
Moore Medical Corp. or any subsequent acquisitions or disposition of equity
securities of Moore Medical Corp. by any of the undersigned.
Date: September 3, 1999
HOLLYBANK INVESTMENTS, LP
By:/s/ Timothy G. Caffrey
----------------------
Timothy G. Caffrey
General Partner
THISTLE INVESTMENTS LLC
By:/s/ Timothy G. Caffrey
----------------------
Timothy G. Caffrey
Managing Member
By:/s/ Timothy G. Caffrey
----------------------
Dorsey R. Gardner
By: Timothy G. Caffrey, Attorney-in-Fact
<PAGE>
EXHIBIT 99.2
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints Timothy G. Caffrey, the undersigned's true and lawful attorney-in-fact
to:
(1) execute for and on behalf of the undersigned, in each the
undersigned's individual capacity, as a general partner by
Hollybank Investments, LP ("LP") and as a managing member of
Thistle Investments LLC ("LLC"), Schedule 13D and any amendments
thereto in accordance with Section 13(d) of the Securities
Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all act for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Schedule 13D and any amendments thereto and
timely file such form with the United States Securities and
Exchange Commission and any stock exchange or similar authority;
and
(3) take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is LP or LLC assuming, any of the undersigned's responsibilities to comply
with Section 13 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D and any amendments
thereto with respect to the undersigned's holdings of and transactions in
securities issued by LP and LLC, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorney-in-fact.
1
<PAGE>
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 3rd day of September, 1999.
/s/Dorsey R. Gardner
----------------------------
Signature
Dorsey R. Gardner, individually and as General
Partner of Hollybank Investments, LP and
Managing Member of Thistle Investments LLC
